hAM for Inferior RRD
Recruiting
N/A
Interventional Study
Rhegmatogenous Retinal Detachment
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 – 70
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 50 (estimated)
- Sponsor
- Eye & ENT Hospital of Fudan University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The objective of the study is to evaluate the efficacy of using hAM patches over the retina to seal inferior retinal breaks. The researchers will evaluate whether hAM patch-assisted vitrectomy improves surgical success rate of retinal reattachment.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
1. Subjects having given free and informed consent to take part in the study.
2. Subjects between 18 and 70 years old.
3. Subjects suffering RRD (both primary and recurrent RRDs) with at least one of these conditions:
1. inferior retinal breaks between 4- and 8-o'clock withi…
Contacts